Prognosis
Vaccine Giant Glaxo Joins Global Race to Combat Coronavirus
- Drugmaker to join forces with CEPI, University of Queensland
- The partners’ goal: make more vaccine available, more rapidly
Health workers in protective suits man a temperature check point for departing travelers at the Hongqiao International Airport in Shanghai, Feb. 2.
Photographer: Qilai Shen/BloombergThis article is for subscribers only.
One of the world’s largest vaccine makers is bringing its technology to the battle against the coronavirus spreading across China and the world.
GlaxoSmithKline Plc and the Coalition for Epidemic Preparedness Innovations said they would work to accelerate the creation of a vaccine. The goal is then to provide many vaccine doses rapidly, according to a statement Monday.